by Deborah Babudoh
The product School event, hosted by Seamfix in her office brought together over 100 Product Manager, product designers, and other tech enthusiasts to share ideas on User-centered product design.
The Product School meetup brings about top PMs/tech mentors and instructors working at renowned tech companies with years of experience in their field to present on topics in product management, coding, data, block chain, digital marketing and many more to help you become a full-stack product manager.
This year’s edition was themed “Building the right products the right way”. The event featured speakers and panelists with extensive product management experiences.
Starting the session was the guest speaker Usman Abiola from Smile identity, he gave a deep dive into Product assessment; building the right product before you think of building the product right, case studies, evaluation etc.
After which the panel session commenced. The panel, made up of 3 experienced product designers and managers; including our very own Product designer Femi Badejo alongside other panelists Usman Abiola (product design manager at from Smile identity) and Lucius Unegbu (product manager at Decagon).
The panelists were asked various questions by the audience ranging from; If you embrace every feedback from the customers? How to manage customers, the right target audience, Budget, product stages, how to conduct proper market research, among other questions.
The meetup was very engaging, interactive and there was a great knowledge exchange. At the conclusion of the event, participants got to take pictures, network and eat!
It was an amazing learning session!
by Deborah Babudoh
In a bid to improve the overall quality of education and skills of the less privileged in the country, Seamfix has donated educational items like laptops, exercise books, pens, pencils and internet to the children of Bethesda Child Support.
We initiated this gesture to put smiles on the faces of the school children, staff, entire management with the gifted items and our cheerful presence. Seamfix assures you that it is not the end of her quest to make an impact and invest bountifully in the future generation”.
This 2020 initiative is themed: Seamfix Making An Impact- An investment in you future. According to the Managing director of Seamfix Mr Chimezie Emewulu “Community development is at the heart of our business which is what we seek to do everyday; inspiring and investing in future leaders of tomorrow”.
Here at Seamfix, we value service to humanity and Community development is at the heart of our business which is what we seek to do everyday; inspiring and investing in future leaders of tomorrow.
Ijeoma Nwachukwu Program Director extended her appreciation to Seamfix for the generous gifts donated to the children of Bethesda Child Support and staff who received them with so much joy and gladness. She went further to commend our commitment to making a difference and helping the underprivileged children secure a better future through education.
Corporate social responsibility isn’t a particular program, it’s what we do every day, maximizing positive impact and minimizing negative impact.” This, we assure you, is not the end of our quest to make an impact and invest bountifully in the future generation.
Click here to watch full video
by Deborah Babudoh
The maiden edition of a Clinical Research summit titled “The Clinical Investigators’ Summit” was organized by Clinique Research Development Limited in partnership with The Global Health Network. This event was held at Radisson Blu Anchorage Hotel, Victoria Island, Lagos State, Nigeria on the 12th of February 2020. The theme of the summit was “Strategy for Collection of Quality Data/Site Preparedness”.
The summit aimed at bringing together pharmaceutical companies, food companies, medical device companies, human development NGOs, Government regulatory bodies, research-active sites, clinical research professionals and study Investigators to share good clinical practices and develop strategic direction for the management of trials in Nigeria. The program intends to propose a system for the development, training, and establishment of ‘accredited’ clinical trial sites in Nigeria.
In attendance to the program are the Director of the National Agency for Food and Drug Administration and Control (NAFDAC) represented by Mr Kayode Amuda, the Lagos State Commissioner for Health represented by Dr, Hussein Abdulrazaq, the Chairperson of the Association of Good Clinical Practice Nigeria (AGCPN) represented by Dr Anthonia Sowunmi, the Chairman of the National Health Research Ethics Committee (NHREC) represented by Dr Ado Danladi.
Other distinguished guests present were Dr Adebayo Adejumo from the Centre for Bioethics and Research; University of Ibadan, Dr Margaret Ekpenyong representing the Director-General of the National Institute of Pharmaceutical Research and Development (NIPRD), Dr Mike Iroezindu who is the Director of Research at the Walter Reed Program Nigeria; U.S. Army Medical Research Directorate, Ms Temi Adeyemi who is the Director of Clinical Operations; Reliance Clinical Limited United Kingdom, the Institute of Human Virology Nigeria (IHVN) represented by Ms Sophia Osarewe, Prof. Oliver Ezechi who is the Director of Research at the Nigerian Institute of Medical Research (NIMR), Dr Adaeze Oreh who is a member of the governing council of PAMO University of Medical Sciences Rivers state.
Each of these guests gave presentations on different areas of expertise that are related to the conduct of clinical trials and epidemiological studies using humans. Their presentations span from the regulatory processes of NAFDAC and NHREC, the importance of quality data management in human studies, the future of young researchers in the field of clinical research, to good clinical practice guidelines.
What are clinical trials?
Clinical trials are experiments or observations done in clinical research. Data/Information collected from these studies/research is the only valid means of understanding the effects of treatments in Humans.
Dr Mike Iroezindu enlightened the audience on the methods and processes to be implemented by study sites for a prospective clinical trial. He stated that “Site preparedness is the key. The reason we end up with challenges and sad stories is because of lack of preparation and that proper planning leads to positive results”.
Prof. Oliver Ezechi emphasized on the need for good clinical data management in conducting clinical trials, starting from the paper data collection, electronic data capture, to the database lock. He ended his presentation with “the ultimate goal of clinical data management is to assure that data support conclusion drawn from trials and achieving this goal protects public health and confidence in marketed therapeutics”.
A panel discussion was held which erupted to different conversations relating to the challenges of conducting clinical trials in Nigeria and the way forward. Representing Seamfix during the panel session was Miss Kosisochukwu ofodile, who was asked this question “What are your contributions in ensuring smooth data management and tight data security in conducting clinical trials and how can you contribute to ensuring this for clinical trial sites?”
She took a deep dive into how a robust data management system like BioRegistra is highly needed in the clinical sites and will promote high quality clinical research, coordinate resources and most importantly gain transparency into the trial research. Giving various use case scenarios on how our cloud platform will help organisations during and after their clinical trial research, she also highlighted key benefits of BioRegistra, from the Offline and online data capture to accessibility and having one unified source for clinical trials.
Once the panel session was concluded, the audience were given time to ask questions and give recommendations. Once this session closed, there was a consensus that clarified to all participants of the event, the quality of research expected from Nigeria on a global scale and the processes to follow to optimize the integrity of clinical trials and epidemiological studies conducted in the country.